Company Search:
Advanced Search
Sponsored Links
Cardiff Oncology Inc Company Snapshot
Cardiff Oncology Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cardiff Oncology Inc with three other companies in this sector in UNITED STATES : Windtree Therapeutics Inc (2019 sales of $198,000.00 of which 100% was Biopharmaceutical and Medical device), AIM ImmunoTech Inc ($140,000.00 ), and Enzon Pharmaceuticals, Inc. ($207,000.00 ).

Sales Analysis. Cardiff Oncology Inc reported sales of $244,632.00 for the year ending December of 2019. This represents a sharp decrease of 35.3% versus 2018, when the company's sales were $378,325.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cardiff Oncology Inc
  Stock Performance Chart for Cardiff Oncology Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/16/2020): 14.91
(Figures in U.S. Dollars)
1 Week -13.6%   13 Weeks 71.2%  
4 Weeks 229.1%   52 Weeks 1,320.0%  
Cardiff Oncology Inc Key Data:
  Ticker: CRDF Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 244,632
(Year Ending Jan 2020).
Employees: 14
  Currency: U.S. Dollars Market Cap: 317,956,883
  Fiscal Yr Ends: December Shares Outstanding: 21,325,076
  Share Type: Common Closely Held Shares: 83,781
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.